Engineered glycated amino dendritic polymers as specific nonviral gene delivery vectors targeting the receptor for advanced glycation end products

Bioconjugate Chemistry

Volumn 25, Issue 6, 2014, Pages 1151-1161

  Dolores Giron Gonzalez, M ^a   Morales Portillo, Arturo ^b   Salinas Castillo, Alfonso ^c   Lopez Jaramillo, F Javier ^a   Hernandez Mateo, Fernando ^b   Santoyo Gonzalez, Francisco ^b   Salto Gonzalez, Rafael ^a  

^a Facultad de Medicina   (Spain)

^b Departamento de Química Organica   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CELL SIGNALING; EFFICIENCY; GENE TRANSFER; GENES; GLYCOSYLATION; LIGANDS; MOLECULAR BIOLOGY;

ADVANCED GLYCATION END PRODUCTS; ANGIOGENESIS; DENDRIPLEXES; GENE DELIVERY VECTORS; LIGAND BINDING; NON-ENZYMATIC; NON-VIRAL GENE DELIVERY; PATHOLOGICAL CONDITIONS; SIGNALLING PATHWAYS; TRANSFECTION EFFICIENCY;

DENDRIMERS;

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHLORPROMAZINE; DANSYLCADAVERINE; DENDRIMER; DEOXYRIBONUCLEASE I; GENISTEIN; NAKED DNA; PLASMID DNA; POLYMER; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CADAVERINE; IMMUNOGLOBULIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA DEGRADATION; DNA TRANSFECTION; ENDOCYTOSIS; FEMALE; GENE VECTOR; GENETIC TRANSFECTION; GLYCATION; IN VIVO GENE TRANSFER; INTERNALIZATION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PROTEIN DETERMINATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL LINE; CELL SURVIVAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; DOSE RESPONSE; DRUG EFFECTS; GENE TRANSFER; GENETIC ENGINEERING; METABOLISM; PHARMACOLOGY; RAT; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; SYNTHESIS;

ANIMALS; CADAVERINE; CELL LINE; CELL SURVIVAL; CHO CELLS; CRICETULUS; DENDRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC VECTORS; MICE; MODELS, BIOLOGICAL; PARTICLE SIZE; POLYMERS; RATS; RECEPTORS, IMMUNOLOGIC; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

EID: 84902660359     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc5001643     Document Type: Article

References (49)

1. Mintzer, M. A. and Simanek, E. E. (2009) Nonviral vectors for gene delivery Chem. Rev. 109, 259-302
2. Glover, D. J., Lipps, H. J., and Jans, D. A. (2005) Towards safe, non-viral therapeutic gene expression in humans Nat. Rev. Genet. 6, 299-310
3. Thomas, C. E., Ehrhardt, A., and Kay, M. A. (2003) Progress and problems with the use of viral vectors for gene therapy Nat. Rev. Genet. 4, 346-358
4. Torchilin, V. P. (2005) Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 4, 145-160
5. Thomas, M. and Klibanov, A. M. (2003) Non-viral gene therapy: polycation-mediated DNA delivery Appl. Microbiol. Biotechnol. 62, 27-34
6. Zhang, S., Xu, Y., Wang, B., Qiao, W., Liu, D., and Li, Z. (2004) Cationic compounds used in lipoplexes and polyplexes for gene delivery J. Controlled Release 100, 165-180
7. Miller, A. D. (2003) The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy Curr. Med. Chem. 10, 1195-1211
8. Bire, S. and Rouleux-Bonnin, F. (2013) Transgene site-specific integration: problems and solutions Top. Curr. Genet. 23, 3-39
9. Kawakami, S., Yamashita, F., Nishida, K., Nakamura, J., and Hashida, M. (2002) Glycosylated cationic liposomes for cell-selective gene delivery Crit. Rev. Ther. Drug Carrier Syst. 19, 171-190
10. Kichler, A., Frisch, B., Lima de Souza, D., and Schuber, F. (2000) Receptor-mediated gene delivery with non-viral DNA carriers J. Liposome Res. 10, 443-460
11. Boutin, V., Legrand, A., Mayer, R., Nachtigal, M., Monsigny, M., and Midoux, P. (1999) Glycofection: the ubiquitous roles of sugar bound on glycoplexes Drug Delivery 6, 45-50
12. Roche, A. C., Fajac, I., Grosse, S., Frison, N., Rondanino, C., Mayer, R., and Monsigny, M. (2003) Glycofection: facilitated gene transfer by cationic glycopolymers Cell. Mol. Life Sci. 60, 288-297
13. Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., and Nawroth, P. P. (2005) Understanding RAGE, the receptor for advanced glycation end products J. Mol. Med. 83, 876-886
14. Stern, D., Yan, S. D., Yan, S. F., and Schmidt, A. M. (2002) Receptor for advanced glycation end products: a multiligand receptor magnifying cell stress in diverse pathologic settings Adv. Drug Delivery Rev. 54, 1615-1625
15. Chavakis, T., Bierhaus, A., and Nawroth, P. P. (2004) RAGE (receptor for advanced glycation end products): a central player in the inflammatory response Microbes and Infection 6, 1219-1225
16. Mahajan, N. and Dhawan, V. (2013) Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases Int. J. Cardiol. 168, 1788-1794
17. Vlassara, H. and Uribarri, J. (2014) Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr. Diabetes Rep. 14, 1-10
18. Singh, R., Barden, A., Mori, T., and Beilin, L. (2001) Advanced glycation end-products: a review Diabetologia 44, 129-146
19. Manigrasso, M. B., Juranek, J., Ramasamy, R., and Schmidt, A. M. (2014) Unlocking the biology of RAGE in diabetic microvascular complications Trends Endocrinol. Metab. 25, 15-22
20. Sevillano, N., Girón, M. D., Salido, M., Vargas, A. M., Vilches, J., and Salto, R. (2009) Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses J. Biochem. 145, 21-30
21. Hudson, B. I., Bucciarelli, L. G., Wendt, T., Sakaguchi, T., Lalla, E., Qu, W., Lu, Y., Lee, L., Stern, D. M., Naka, Y., Ramasamy, R., Yan, S. D., Yan, S. F., DAgati, V., and Schmidt, A. M. (2003) Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders Arch. Biochem. Biophys. 419, 80-88
22. Zlokovic, B. V. (2008) New therapeutic targets in the neurovascular pathway in Alzheimer's disease Neurotherapeutics 5, 409-414
23. Logsdon, C. D., Fuentes, M. K., Huang, E. H., and Arumugam, T. (2007) RAGE and RAGE ligands in cancer Curr. Mol. Med. 7, 777-789
24. Bierhaus, A., Stern, D. M., and Nawroth, P. P. (2006) RAGE in inflammation: a new therapeutic target? Curr. Opin. Invest. Drugs 7, 985-991
25. Dufes, C., Uchegbu, I. F., and Schaetzlein, A. G. (2005) Dendrimers in gene delivery Adv. Drug Delivery Rev. 57, 2177-2202
26. Lungwitz, U., Breunig, M., Blunk, T., and Goepferich, A. (2005) Polyethylenimine-based non-viral gene delivery systems Eur. J. Pharm. Biopharm. 60, 247-266
27. Morales-Sanfrutos, J., Megia-Fernandez, A., Hernandez-Mateo, F., Giron-Gonzalez, M. D., Salto-Gonzalez, R., and Santoyo-Gonzalez, F. (2011) Alkyl sulfonyl derivatized PAMAM-G2 dendrimers as nonviral gene delivery vectors with improved transfection efficiencies Org. Biomol. Chem. 9, 851-864
28. Shen, J., Zhao, D. J., Li, W., Hu, Q. L., Wang, Q. W., Xu, F. J., and Tang, G. P. (2013) A polyethylenimine-mimetic biodegradable polycation gene vector and the effect of amine composition in transfection efficiency Biomaterials 34, 4520-4531
29. Boussif, O., LezoualCH, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301
30. Hudson, B. I., Kalea, A. Z., Arriero, M. D., Harja, E., Boulanger, E., DAgati, V., and Schmidt, A. M. (2008) Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 J. Biol. Chem. 283, 34457-34468
31. Song, F. and Schmidt, A. M. (2012) Glycation and insulin resistance: novel mechanisms and unique targets? Arterioscler., Thromb., Vasc. Biol. 32, 1760-5
32. Schmidt, A. M., Yan, S. D., Wautier, J. L., and Stern, D. (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ. Res. 84, 489-97
33. Arumugam, T., Ramachandran, V., Gomez, S. B., Schmidt, A. M., and Logsdon, C. D. (2012) S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis Clin. Cancer Res. 18, 4356-4364
34. Leclercq, F., Dubertret, C., Pitard, B., Scherman, D., and Herscovici, J. (2000) Synthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency Bioorg. Med. Chem. Lett. 10, 1233-1235
35. Crini, G. (2005) Recent developments in polysaccharide-based materials used as adsorbents in wastewater treatment Prog. Polym. Sci. 30, 38-70
36. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J. Immunol. Methods 65, 55-63
37. Makita, Z., Vlassara, H., Cerami, A., and Bucala, R. (1992) Immunochemical detection of advanced glycosylation end products in vivo J. Biol. Chem. 267, 5133-8
38. Labieniec, M. and Watala, C. (2010) Use of poly(amido)amine dendrimers in prevention of early non-enzymatic modifications of biomacromolecules Biochimie 92, 1296-1305
39. Labieniec, M., Ulicna, O., Vancova, O., Glowacki, R., Sebekova, K., Bald, E., Gabryelak, T., and Watala, C. (2008) PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats Int. J. Pharm. 364, 142-9
40. Thornalley, P. J., Battah, S., Ahmed, N., Karachalias, N., Agalou, S., Babaei-Jadidi, R., and Dawnay, A. (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry Biochem. J. 375, 581-92
41. Rejman, J., Oberle, V., Zuhorn, I. S., and Hoekstra, D. (2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis Biochem. J. 377, 159-169
42. Vercauteren, D., Vandenbroucke, R. E., Jones, A. T., Rejman, J., Demeester, J., De Smedt, S. C., Sanders, N. N., and Braeckmans, K. (2010) The use of inhibitors to study endocytic pathways of gene carriers: Optimization and pitfalls Mol. Ther. 18, 561-569
43. Schütze, S., Machleidt, T., Adam, D., Schwandner, R., Wiegmann, K., Kruse, M. L., Heinrich, M., Wickel, M., and Krönke, M. (1999) Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling J. Biol. Chem. 274, 10203-10212
44. Chen, S. C., Guh, J. Y., Hwang, C. C., Chiou, S. J., Lin, T. D., Ko, Y. M., Huang, J. S., Yang, Y. L., and Chuang, L. Y. (2010) Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts J. Cell Biochem. 109, 38-48
45. Wu, C. H., Huang, H. W., Lin, J. A., Huang, S. M., and Yen, G. C. (2011) The proglycation effect of caffeic acid leads to the elevation of oxidative stress and inflammation in monocytes, macrophages and vascular endothelial cells J. Nutr. Biochem. 22, 585-594
46. Sterzel, W., Bedford, P., and Eisenbrand, G. (1985) Automated determination of DNA using the fluorochrome Hoechst 33258 Anal. Biochem. 147, 462-467
47. Cayot, P. and Tainturier, G. (1997) The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: a reexamination Anal. Biochem. 249, 184-200
48. Girón, M. D., Sevillano, N., Vargas, A. M., Domínguez, J., Guinovart, J. J., and Salto, R. (2008) The glucose-lowering agent sodium tungstate increases the levels and translocation of GLUT4 in L6 myotubes through a mechanism associated with ERK1/2 and MEF2D Diabetologia 51, 1285-1295
49. Rasband, W. S. and Bright, D. S. (1995) NIH Image: a public domain image processing program for the Macintosh Microbeam Anal. (Deerfield Beach, Fla.) 4, 137-149